INCR
Price
$5.42
Change
+$0.16 (+3.04%)
Updated
Sep 4 closing price
Capitalization
81.32M
72 days until earnings call
Intraday BUY SELL Signals
TRLV
Price
$12.11
Change
+$0.12 (+1.00%)
Updated
Sep 4 closing price
Capitalization
2.33B
66 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

INCR vs TRLV

INCR vs TRLV Comparison Chart in %
loading
loading
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teva Pharmaceutical Industries Limited (NYSE:TEVA), ZOETIS (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN), BioCryst Pharmaceuticals (NASDAQ:BCRX), Bausch Health Companies (NYSE:BHC), Tilray Brands Inc. (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

Market Cap

The average market capitalization across the Pharmaceuticals: Generic Industry is 4.09B. The market cap for tickers in the group ranges from 2.12K to 63.66B. AGN holds the highest valuation in this group at 63.66B. The lowest valued company is CANQF at 2.12K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Generic Industry was -1%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 37%. GELS experienced the highest price growth at 62%, while BTAI experienced the biggest fall at -59%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Generic Industry was -12%. For the same stocks of the Industry, the average monthly volume growth was -36% and the average quarterly volume growth was 73%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 64
Price Growth Rating: 55
SMR Rating: 88
Profit Risk Rating: 82
Seasonality Score: -15 (-100 ... +100)

Market Cap

The average market capitalization across the group is 1.21B. The market cap for tickers in the group ranges from 81.32M to 2.33B. TRLV holds the highest valuation in this group at 2.33B. The lowest valued company is INCR at 81.32M.

High and low price notable news

The average weekly price growth across all stocks in the group was -2%. For the same group, the average monthly price growth was 28%, and the average quarterly price growth was 58%. TRLV experienced the highest price growth at 2%, while INCR experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the group was 53%. For the same stocks of the group, the average monthly volume growth was 203% and the average quarterly volume growth was 100%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 9
Price Growth Rating: 41
SMR Rating: 93
Profit Risk Rating: 100
Seasonality Score: 0 (-100 ... +100)
VS
INCR vs. TRLV commentary
Sep 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INCR is a Hold and TRLV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2026
Stock price -- (INCR: $5.42 vs. TRLV: $12.11)
Brand notoriety: INCR and TRLV are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: INCR: 31% vs. TRLV: 132%
Market capitalization -- INCR: $81.32M vs. TRLV: $2.33B
INCR [@Pharmaceuticals: Generic] is valued at $81.32M. TRLV’s [@Pharmaceuticals: Generic] market capitalization is $2.33B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INCR’s FA Score shows that 1 FA rating(s) are green whileTRLV’s FA Score has 1 green FA rating(s).

  • INCR’s FA Score: 1 green, 4 red.
  • TRLV’s FA Score: 1 green, 4 red.
According to our system of comparison, INCR is a better buy in the long-term than TRLV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INCR’s TA Score shows that 4 TA indicator(s) are bullish while TRLV’s TA Score has 6 bullish TA indicator(s).

  • INCR’s TA Score: 4 bullish, 7 bearish.
  • TRLV’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, TRLV is a better buy in the short-term than INCR.

Price Growth

INCR (@Pharmaceuticals: Generic) experienced а -6.23% price change this week, while TRLV (@Pharmaceuticals: Generic) price change was +2.45% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.17%. For the same industry, the average monthly price growth was +0.32%, and the average quarterly price growth was +36.80%.

Reported Earning Dates

INCR is expected to report earnings on Nov 17, 2026.

TRLV is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.17% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRLV($2.33B) has a higher market cap than INCR($81.3M). TRLV YTD gains are higher at: 39.356 vs. INCR (19.121).
INCRTRLVINCR / TRLV
Capitalization81.3M2.33B3%
EBITDA-7.29MN/A-
Gain YTD19.12139.35649%
P/E Ratio25.48N/A-
Revenue270MN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
INCR vs TRLV: Fundamental Ratings
INCR
TRLV
OUTLOOK RATING
1..100
5047
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
74
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9393
PRICE GROWTH RATING
1..100
4636
P/E GROWTH RATING
1..100
414
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INCR's Valuation (50) in the Servicestothe Health Industry industry is in the same range as TRLV (74) in the null industry. This means that INCR’s stock grew similarly to TRLV’s over the last 12 months.

INCR's Profit vs Risk Rating (100) in the Servicestothe Health Industry industry is in the same range as TRLV (100) in the null industry. This means that INCR’s stock grew similarly to TRLV’s over the last 12 months.

INCR's SMR Rating (93) in the Servicestothe Health Industry industry is in the same range as TRLV (93) in the null industry. This means that INCR’s stock grew similarly to TRLV’s over the last 12 months.

TRLV's Price Growth Rating (36) in the null industry is in the same range as INCR (46) in the Servicestothe Health Industry industry. This means that TRLV’s stock grew similarly to INCR’s over the last 12 months.

INCR's P/E Growth Rating (4) in the Servicestothe Health Industry industry is in the same range as TRLV (14) in the null industry. This means that INCR’s stock grew similarly to TRLV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INCRTRLV
RSI
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 5 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 12 days ago
69%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
INCR
Daily Signal:
Gain/Loss:
TRLV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ASCGX26.290.09
+0.34%
Lisanti Small Cap Growth
THORX54.320.05
+0.09%
Thornburg Global Opportunities R3
NEMCX28.39N/A
N/A
Neuberger Emerg Mkts Eq C
HFERX64.12N/A
N/A
Janus Henderson European Focus N
MIRTX35.00-0.10
-0.28%
MFS Massachusetts Investors Tr R2

INCR and Stocks

Correlation & Price change

A.I.dvisor tells us that INCR and TLRY have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INCR and TLRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCR
1D Price
Change %
INCR100%
+3.04%
TLRY - INCR
27%
Poorly correlated
-0.66%
SNDL - INCR
25%
Poorly correlated
+1.77%
AKAN - INCR
24%
Poorly correlated
-8.72%
TRLV - INCR
23%
Poorly correlated
+1.00%
CRON - INCR
23%
Poorly correlated
N/A
More

TRLV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TRLV has been closely correlated with GLAS. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRLV jumps, then GLAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRLV
1D Price
Change %
TRLV100%
+1.00%
GLAS - TRLV
72%
Closely correlated
+3.26%
CGC - TRLV
69%
Closely correlated
-0.02%
ACB - TRLV
65%
Loosely correlated
+1.54%
CRON - TRLV
61%
Loosely correlated
N/A
OGI - TRLV
54%
Loosely correlated
-1.28%
More